Brief: Aileron Therapeutics Reports Q3 Loss Per Share $0.07

Rein Therapeutics

12/11/2021 12:54

Nov 12 (Reuters) - Aileron Therapeutics Inc  ALRN.O :
    * AILERON THERAPEUTICS REPORTS THIRD QUARTER 2021 FINANCIAL
RESULTS AND BUSINESS HIGHLIGHTS
    * Q3 LOSS PER SHARE $0.07
    * Q3 EARNINGS PER SHARE VIEW $-0.07 -- REFINITIV IBES DATA
    * $52.2 MILLION CASH AND CASH EQUIVALENTS AS OF SEPTEMBER
30,
2021, EXPECTED TO FUND OPERATIONS INTO SECOND HALF OF 2023

Source text for Eikon:  ID:nGNX9kD4Gj 
Further company coverage:  ALRN.O 

 ((Reuters.Briefs@thomsonreuters.com;))